Less Ads, More Data, More Tools Register for FREE

Pin to quick picksS & U Regulatory News (SUS)

Share Price Information for S & U (SUS)

Share Price is delayed by 15 minutes
Get Live Data
1,915.00    -10.00 (-0.52%)
Bid:
1,910.00
Ask:
1,945.00
Spread: 35.00 (1.832%)
Market Cap: £232.69m
SUS Live PriceLast checked at - London Stock Exchange

Intraday S & U Share Chart

Trading Statement

11 Aug 2010 07:00

RNS Number : 8685Q
S & U PLC
11 August 2010
Β 

ο»Ώ

11 August 2010

Β 

S&U PLC ("S&U" or "the Company")

Trading Update

Notice of Results

Β 

Β 

S&U, Britain's foremost niche home credit and motor finance provider, today announces a trading update for the six months to the 31st July 2010. The Company is please to announce that it is trading in line with market expectations and intends to issue its interim results on 23 September 2010.

Β 

Home Credit

Loansathome4u, our home credit business, has maintained its progress by increasing revenues by 2% in the period against last year and by adding an additional 4000 customers versus a year ago. Collections have remained robust increasing by 3.5% on last year whilst impairment charges have remained stable and well controlled. These trends reflect the way in which our customers value, and have an appetite for, the service and loan finance we offer, despite the current economic uncertainty and the coalition Government's impending Welfare Review. We are therefore confident that our traditionally tight control over administrative expenses and our cautious approach to underwriting will now prove their worth in more austere times. We remain optimistic and continue to expand our business.

Β 

Β Motor Finance

Advantage, our motor finance business, has more than maintained the excellent start it made to the financial year. In a market where competition remains subdued, Advantage's growing reputation has seen revenues increase by nearly a quarter on last year. Margins continue to improve whilst the quality of both new customers and the book as a whole is very encouraging, as evidenced by three consecutive months of record collections in this period. Impairment levels reflect this. We are optimistic about Advantage's continued progress.

Β 

Funding and Capital

Strong trading must be reflected in strong cash flow and S&U's financial position confirms this. During the period we have paid off Β£4m worth of loans, reduced our overall borrowings, both absolutely and relative to last year, and seen gearing fall below 53%. Our headroom for both organic expansion and acquisitions, as well as shareholder returns, has further increased.

Β 

Outlook

Our current trading, stable and expanding customer base and a stable regulatory environment under a new Government, as well as a balanced and benign OFT High Cost Credit Review, all make for optimism for the current year's outturn.

Β 

Commenting, Mr Anthony Coombs, S&U Chairman, said "Particularly in these uncertain times, attention to detail and close relationships with our loyal customers bring their own reward. Improving standards and our current trading both inspire confidence for the future".

Β 

Anthony Coombs

Chairman

Β 

Β 

For further information, please contact:

Β 

S&U plc www.suplc.co.ukΒ 

Anthony Coombs, Chairman 0121 705 7777

Β 

Charles Stanley Securities

Mark Taylor / Dugald Carlean 020 7149 6000

Β 

Smithfield

Rupert Trefgarne/ Rebecca Whitehead 020 7360 4900

Β 

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
TSTBLGDIBDBBGGG
Date   Source Headline
25th May 20237:00 amRNSAGM Statement and Trading Update
25th Apr 20232:00 pmRNSAnnual Report and Accounts
25th Apr 202311:48 amRNSDirector/PDMR Shareholding
20th Apr 20237:00 amRNSMello Investor Presentation
6th Apr 20234:08 pmRNSAnnouncement of Annual Report and Accounts
28th Mar 20234:35 pmRNSPrice Monitoring Extension
28th Mar 20237:00 amRNSPreliminary Results
23rd Mar 20234:35 pmRNSPrice Monitoring Extension
28th Feb 20237:00 amRNSResults Presentations for Analysts and Investors
14th Feb 20232:00 pmRNSAppointment of Executive Director
9th Feb 20237:00 amRNSTrading Statement and Notice of Results
8th Dec 20227:00 amRNSTrading Statement
27th Sep 20227:00 amRNSInterim Results
30th Aug 20227:00 amRNSResults Presentations for Analysts and Investors
18th Aug 20224:36 pmRNSPrice Monitoring Extension
10th Aug 20227:00 amRNSTrading Update and Notice of Results
3rd Aug 20224:40 pmRNSSecond Price Monitoring Extn
3rd Aug 20224:35 pmRNSPrice Monitoring Extension
8th Jul 20225:06 pmRNSDirector/PDMR and PCA Shareholding
1st Jun 20227:00 amRNSTotal Voting Rights
26th May 202212:33 pmRNSResult of AGM
26th May 20227:00 amRNSAGM Statement and Trading Update
23rd May 20227:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
18th May 202211:30 amRNSOptions, Director/PDMR Shareholding, Voting Rights
13th May 20224:33 pmRNSDirector/PDMR Shareholding
5th May 20221:53 pmRNSDirector/PDMR Shareholding, Options, Voting Rights
26th Apr 20222:00 pmRNSAnnual Report and Accounts
4th Apr 20227:00 amEQSEdison Investment Research Limited: S&U (SUS): Seeing recovery and adapting to grow
4th Apr 20227:00 amRNSAnnual Report and Accounts
29th Mar 20227:00 amRNSPreliminary Results
9th Mar 20227:00 amRNSResults Presentations for Analysts and Investors
10th Feb 20227:00 amRNSTrading Statement and Notice of Results
17th Jan 20222:39 pmRNSAppointment of non-executive director
17th Jan 20222:33 pmRNSDirector/PDMR Shareholding
9th Dec 20217:00 amRNSTrading Statement
7th Dec 20217:00 amRNSBlock Listing Application
23rd Nov 20217:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
29th Oct 20219:46 amRNSDirector/PDMR Shareholding
6th Oct 20217:00 amRNSDirector/PDMR Shareholding
28th Sep 20217:00 amRNSInterim Results
22nd Sep 20217:00 amRNSInvestor Presentation
10th Aug 20217:00 amRNSTrading Update and Notice of Results
23rd Jul 20214:50 pmRNSDirector/PDMR Shareholding
30th Jun 20214:02 pmRNSDirector/PDMR Shareholding
24th May 20217:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
20th May 202110:00 amRNSResult of AGM
20th May 20217:00 amRNSAGM Statement and Trading Update
23rd Apr 20211:00 pmRNSAnnual Report and Accounts
16th Apr 20215:37 pmRNSDirector/PDMR Shareholding and Total Voting Rights
14th Apr 20219:54 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.